欧司美特 Osteometer MediTech
骨质疏松症是一种会使30-40%的妇女在她们有生之年面临骨质疏松性骨折危险的疾病,这种风险在男性,大约在13%*.

欧司美特 (Osteometer MediTech) 公司致力于提供一种客户买得起的,高质量的,可用于普通门诊室,诊断骨质疏松症的骨密度仪,自第一台机器离开工厂,十多年来我们已卖出了数千台骨密度仪,今天, 欧司美特 (Osteometer MediTech) 公司已经是全球范围内数个国家的门诊室骨密度仪市场的领导者.

高品质和高可靠性是欧司美特 (Osteometer MediTech) 公司的核心因素,从研发到生产, 欧司美特 (Osteometer MediTech) 公司严格遵从下列标准:

IEC 60601-1-2 Medical Electrical Equipment
The Medical Device Directive (93/42/EEC)
ISO 13485:2003(E)
另外, 欧司美特 (Osteometer MediTech) 公司的产品还遵从(FDA),CFR Part 21, Title 820(GMP).

作为骨质疏松症诊断产品市场的主要成员,欧司美特 (Osteometer MediTech) 公司,承诺致力于开发和生产科技含量高,临床又欢迎的骨密度产品.实践也已证明,我们的产品精确度准确率具佳,可靠性好,性价比高,使尽量多的病人接受检测成为可能.

Osteoporosis is a disease that gives women a risk of 30-40% of having an osteoporotic fracture in their lifetime. The lifetime risk for men is approximately 13%.*

Osteometer MediTech's focus is on offering affordable, high quality office based scanners and densitometers for diagnosis of osteoporosis. Since the first densitometer left the factory more than ten years ago, several thousand densitometers have followed, and today Osteometer MediTech is the market leader in office based densitometry in several countries around the globe.

Quality and reliability are key elements for Osteometer MediTech. From development to manufacturing, Osteometer MediTech complies with the following standards:

IEC 60601-1-2 Medical Electrical Equipment (General requirements for safety)
The Medical Device Directive (93/42/EEC)
ISO 13485: 2003 (E)
Furthermore, Osteometer's products are in compliance with the Food, Drug and Cosmetic Act (FDA), CFR Part 21, Title 820 (GMP).

Being one of the main market players within diagnosis of osteoporosis, Osteometer MediTech is committed to developing scientifically and clinically validated devices. This has resulted in accurate, precise, reliable and cost-effective scanners, making the diagnostic test accessible to as many patients as possible.